BioNTech SE - stock earnings

BNTX Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
Aug. 5, 2024 BeforeMarket - / - 71.3 million - / 167.1 million 334.4 million

BNTX Quarterly earnings

DateEarningsRevenue
2024Q1 -340.1 million USD 202.5 million USD
2023Q4 506.2 million USD 1.6 billion USD
2023Q3 170.0 million USD 947.8 million USD
2023Q2 -207.0 million USD 182.3 million USD
2023Q1 547.4 million USD 1.4 billion USD
2022Q4 2.4 billion USD 4.6 billion USD
2022Q3 1.8 billion USD 3.4 billion USD
2022Q2 1.7 billion USD 3.3 billion USD
2022Q1 4.1 billion USD 7.1 billion USD
2021Q4 3.6 billion USD 6.3 billion USD
2021Q3 3.7 billion USD 7.1 billion USD
2021Q2 3.3 billion USD 6.3 billion USD
2021Q1 1.3 billion USD 2.4 billion USD
2020Q4 446.9 million USD 420.7 million USD
2020Q3 -246.4 million USD 79.1 million USD
2020Q2 -99.2 million USD 46.9 million USD
2020Q1 -58.9 million USD 30.5 million USD
2019Q4 -65.2 million USD 31.4 million USD
2019Q3 -32.9 million USD 31.4 million USD
2019Q2 -57.0 million USD 29.3 million USD
2019Q1 -45.6 million USD 29.4 million USD
2018Q4 -1.5 million USD 73.0 million USD
2018Q3 -27.3 million USD 23.7 million USD
2018Q2 -26.9 million USD 50.2 million USD

BNTX Yearly earnings

DateEarningsRevenue
2023 1.0 billion USD 4.2 billion USD
2022 10.1 billion USD 18.6 billion USD
2021 11.7 billion USD 21.6 billion USD
2020 18.5 million USD 587.4 million USD
2019 -200.7 million USD 121.6 million USD
2018 -54.9 million USD 145.9 million USD
2017 -102.3 million USD 73.6 million USD

BNTX

Price: $90.61

52 week price:
85.21
125.83

Earnings Per Share: 4.11 USD

P/E Ratio: 7.68

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 379200

Market Capitalization: 22.1 billion

Links: